1616887-33-2Relevant academic research and scientific papers
The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system
Rechenmacher, Florian,Steigerwald, Kristin,Laufer, Burkhardt,Neubauer, Stefanie,Kapp, Tobias G.,Li, Liang,Mas-Moruno, Carlos,Joner, Michael,Kessler, Horst
, p. 1413 - 1418 (2014)
The use of highly active and selective integrin ligands in combination with stent implantation is emerging as a promising alternative to the release of classical immunosuppressive drugs by current drug-eluting stents (DES), which has been associated with
